Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi’s Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36

• Neal D. Shore

Affiliations

Neal D. Shore

Carolina Urologic Research Center, 823 82nd Parkway, Myrtle Beach, SC 29572, USA. Fax: +1 843 4976171.; Carolina Urologic Research Center, Myrtle Beach, SC, USA